1
|
Acharya D, Miller I, Cui Y, Braun DR, Berres ME, Styles MJ, Li L, Kwan J, Rajski SR, Blackwell HE, Bugni TS. Omics Technologies to Understand Activation of a Biosynthetic Gene Cluster in Micromonospora sp. WMMB235: Deciphering Keyicin Biosynthesis. ACS Chem Biol 2019; 14:1260-1270. [PMID: 31120241 PMCID: PMC6591704 DOI: 10.1021/acschembio.9b00223] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
![]()
DNA
sequencing of a large collection of bacterial genomes reveals
a wealth of orphan biosynthetic gene clusters (BGCs) with no identifiable
products. BGC silencing, for those orphan clusters that are truly
silent, rather than those whose products have simply evaded detection
and cluster correlation, is postulated to result from transcriptional
inactivation of these clusters under standard laboratory conditions.
Here, we employ a multi-omics approach to demonstrate how interspecies
interactions modulate the keyicin producing kyc cluster
at the transcriptome level in cocultures of kyc-bearing Micromonospora sp. and a Rhodococcus sp.
We further correlate coculture dependent changes in keyicin production
to changes in transcriptomic and proteomic profiles and show that
these changes are attributable to small molecule signaling consistent
with a quorum sensing pathway. In piecing together the various elements
underlying keyicin production in coculture, this study highlights
how omics technologies can expedite future efforts to understand and
exploit silent BGCs.
Collapse
Affiliation(s)
- Deepa Acharya
- Pharmaceutical Sciences Division, University of Wisconsin—Madison, Madison, Wisconsin 53705, United States
| | - Ian Miller
- Pharmaceutical Sciences Division, University of Wisconsin—Madison, Madison, Wisconsin 53705, United States
| | - Yusi Cui
- Pharmaceutical Sciences Division, University of Wisconsin—Madison, Madison, Wisconsin 53705, United States
| | - Doug R. Braun
- Pharmaceutical Sciences Division, University of Wisconsin—Madison, Madison, Wisconsin 53705, United States
| | - Mark E. Berres
- Bioinformatics Resource Center, University of Wisconsin—Madison, Madison, Wisconsin 53706, United States
| | - Matthew J. Styles
- Department of Chemistry, University of Wisconsin—Madison, Madison, Wisconsin 53706, United States
| | - Lingjun Li
- Pharmaceutical Sciences Division, University of Wisconsin—Madison, Madison, Wisconsin 53705, United States
| | - Jason Kwan
- Pharmaceutical Sciences Division, University of Wisconsin—Madison, Madison, Wisconsin 53705, United States
| | - Scott R. Rajski
- Pharmaceutical Sciences Division, University of Wisconsin—Madison, Madison, Wisconsin 53705, United States
| | - Helen E. Blackwell
- Department of Chemistry, University of Wisconsin—Madison, Madison, Wisconsin 53706, United States
| | - Tim S. Bugni
- Pharmaceutical Sciences Division, University of Wisconsin—Madison, Madison, Wisconsin 53705, United States
| |
Collapse
|
2
|
Adnani N, Chevrette MG, Adibhatla SN, Zhang F, Yu Q, Braun DR, Nelson J, Simpkins SW, McDonald BR, Myers CL, Piotrowski JS, Thompson CJ, Currie CR, Li L, Rajski SR, Bugni TS. Coculture of Marine Invertebrate-Associated Bacteria and Interdisciplinary Technologies Enable Biosynthesis and Discovery of a New Antibiotic, Keyicin. ACS Chem Biol 2017; 12:3093-3102. [PMID: 29121465 DOI: 10.1021/acschembio.7b00688] [Citation(s) in RCA: 79] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Advances in genomics and metabolomics have made clear in recent years that microbial biosynthetic capacities on Earth far exceed previous expectations. This is attributable, in part, to the realization that most microbial natural product (NP) producers harbor biosynthetic machineries not readily amenable to classical laboratory fermentation conditions. Such "cryptic" or dormant biosynthetic gene clusters (BGCs) encode for a vast assortment of potentially new antibiotics and, as such, have become extremely attractive targets for activation under controlled laboratory conditions. We report here that coculturing of a Rhodococcus sp. and a Micromonospora sp. affords keyicin, a new and otherwise unattainable bis-nitroglycosylated anthracycline whose mechanism of action (MOA) appears to deviate from those of other anthracyclines. The structure of keyicin was elucidated using high resolution MS and NMR technologies, as well as detailed molecular modeling studies. Sequencing of the keyicin BGC (within the Micromonospora genome) enabled both structural and genomic comparisons to other anthracycline-producing systems informing efforts to characterize keyicin. The new NP was found to be selectively active against Gram-positive bacteria including both Rhodococcus sp. and Mycobacterium sp. E. coli-based chemical genomics studies revealed that keyicin's MOA, in contrast to many other anthracyclines, does not invoke nucleic acid damage.
Collapse
Affiliation(s)
- Navid Adnani
- Pharmaceutical
Sciences Division, School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705, United States
| | - Marc G. Chevrette
- Department
of Bacteriology, University of Wisconsin, Madison, Wisconsin 53705, United States
- Department
of Genetics, University of Wisconsin, Madison, Wisconsin 53705, United States
| | - Srikar N. Adibhatla
- Pharmaceutical
Sciences Division, School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705, United States
| | - Fan Zhang
- Pharmaceutical
Sciences Division, School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705, United States
| | - Qing Yu
- Pharmaceutical
Sciences Division, School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705, United States
| | - Doug R. Braun
- Pharmaceutical
Sciences Division, School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705, United States
| | - Justin Nelson
- Bioinformatics
and Computational Biology Program, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, United States
| | - Scott W. Simpkins
- Bioinformatics
and Computational Biology Program, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, United States
| | - Bradon R. McDonald
- Department
of Bacteriology, University of Wisconsin, Madison, Wisconsin 53705, United States
| | - Chad L. Myers
- Bioinformatics
and Computational Biology Program, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, United States
- Department
of Computer Science and Engineering, University of Minnesota-Twin Cities, Minneapolis, Minnesota 55455, United States
| | | | | | - Cameron R. Currie
- Department
of Bacteriology, University of Wisconsin, Madison, Wisconsin 53705, United States
| | - Lingjun Li
- Pharmaceutical
Sciences Division, School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705, United States
| | - Scott R. Rajski
- Pharmaceutical
Sciences Division, School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705, United States
| | - Tim S. Bugni
- Pharmaceutical
Sciences Division, School of Pharmacy, University of Wisconsin, Madison, Wisconsin 53705, United States
| |
Collapse
|